[
  {
    "ts": null,
    "headline": "AbbVie Inc. stock outperforms competitors on strong trading day",
    "summary": "AbbVie Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=8db86fe202c12ad185eded3273b676e59824a686839cc19efaf486be7ad96d48",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740760260,
      "headline": "AbbVie Inc. stock outperforms competitors on strong trading day",
      "id": 132956579,
      "image": "",
      "related": "ABBV",
      "source": "MarketWatch",
      "summary": "AbbVie Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=8db86fe202c12ad185eded3273b676e59824a686839cc19efaf486be7ad96d48"
    }
  },
  {
    "ts": null,
    "headline": "John Hancock Global Shareholder Yield Fund Q4 2024 Commentary",
    "summary": "The John Hancock Global Shareholder Yield Fund underperformed the benchmark. Click here to read the full commentary.",
    "url": "https://finnhub.io/api/news?id=f5a2038515119372a46b50d00e6ae273f1041b0aca5b754202113786e03e97d3",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740740100,
      "headline": "John Hancock Global Shareholder Yield Fund Q4 2024 Commentary",
      "id": 132906173,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1555288165/image_1555288165.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "The John Hancock Global Shareholder Yield Fund underperformed the benchmark. Click here to read the full commentary. ",
      "url": "https://finnhub.io/api/news?id=f5a2038515119372a46b50d00e6ae273f1041b0aca5b754202113786e03e97d3"
    }
  },
  {
    "ts": null,
    "headline": "John Hancock Disciplined Value Fund Q4 2024 Commentary",
    "summary": "The John Hancock Disciplined Value Fund outperformed the benchmark for 2024. Click here to read the full commentary.",
    "url": "https://finnhub.io/api/news?id=1a10c14383f2115762f0e072f63b1270c3a2e3a3baf035bfaddb39f861964b91",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740726600,
      "headline": "John Hancock Disciplined Value Fund Q4 2024 Commentary",
      "id": 132904708,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2197536685/image_2197536685.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "The John Hancock Disciplined Value Fund outperformed the benchmark for 2024. Click here to read the full commentary. ",
      "url": "https://finnhub.io/api/news?id=1a10c14383f2115762f0e072f63b1270c3a2e3a3baf035bfaddb39f861964b91"
    }
  },
  {
    "ts": null,
    "headline": "Drug Stocks Are the New Safe Bet in a Shaky Market",
    "summary": "Drug Stocks Are the New Safe Bet in a Shaky Market",
    "url": "https://finnhub.io/api/news?id=9cbf52ef07edbc5bfcfb2610a217677b7f12f0522f3e65f5864ff7326854f3b8",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740726000,
      "headline": "Drug Stocks Are the New Safe Bet in a Shaky Market",
      "id": 132907806,
      "image": "",
      "related": "ABBV",
      "source": "DowJones",
      "summary": "Drug Stocks Are the New Safe Bet in a Shaky Market",
      "url": "https://finnhub.io/api/news?id=9cbf52ef07edbc5bfcfb2610a217677b7f12f0522f3e65f5864ff7326854f3b8"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie Gets CHMP Backing of Rinvoq in Giant Cell Arteritis",
    "summary": "By Colin Kellaher AbbVie said the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended expanded approval of its blockbuster autoimmune drug Rinvoq for the...",
    "url": "https://finnhub.io/api/news?id=6a2492c5cca76680c36e92f89afe7c653ef987d84ea78b435677662c1aae86ec",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740725419,
      "headline": "AbbVie Gets CHMP Backing of Rinvoq in Giant Cell Arteritis",
      "id": 132904531,
      "image": "",
      "related": "ABBV",
      "source": "Finnhub",
      "summary": "By Colin Kellaher AbbVie said the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended expanded approval of its blockbuster autoimmune drug Rinvoq for the...",
      "url": "https://finnhub.io/api/news?id=6a2492c5cca76680c36e92f89afe7c653ef987d84ea78b435677662c1aae86ec"
    }
  }
]